• Search Research Projects
  • Search Researchers
  • How to Use
  1. Back to previous page

Molecular dissection of the leukemia-associated transcription factor, AML1/RUNX1,in hematopoietic regulation

Research Project

Project/Area Number 14570990
Research Category

Grant-in-Aid for Scientific Research (C)

Allocation TypeSingle-year Grants
Section一般
Research Field Hematology
Research InstitutionKyoto Prefectural University of Medicine

Principal Investigator

OKUDA Tsukasa  Kyoto Prefectural University of Medicine, Graduate School of Medical Science, Department of Molecular-Targeting Cancer Prevention, Assistant Professor (Kohshi), 医学研究科, 講師 (30291587)

Project Period (FY) 2002 – 2003
Project Status Completed (Fiscal Year 2003)
Budget Amount *help
¥4,100,000 (Direct Cost: ¥4,100,000)
Fiscal Year 2003: ¥1,900,000 (Direct Cost: ¥1,900,000)
Fiscal Year 2002: ¥2,200,000 (Direct Cost: ¥2,200,000)
KeywordsAML1 / leukemia / RUNX / thymus / myelodysplastic syndrome / T-lymphocyte / hematopoiesis / knock-in mouse / RUNX1 / 転写因子 / 造血幹細胞
Research Abstract

Acute Myeloid Leukemia 1 (AML1; also called as Runt-Related Transcription Factor 1: RUNX1) encodes a transcription factor which plays a pivotal role in early development of definitive hematopoiesis, and is the most frequent target of the leukemia-associated gene aberration. In this study, we examined its function along with normal and leukemic hematopoiesis by means of hematopoietic rescue assay at embryonic stem cell and entire mouse levels. What we found are summarized as follows:
1.Transcription-repressive function of AML1,which is mediated through its C-terminal VWRPY-motif, is not essential for the early hematopoietic development in the context of the entire mouse.
2.Genome-modified mouse lines which homozygously harbor knocked-in AML1 allele lacking of VWRPY-motif revealed that the genetically conserved VWRPY-motif plays an important role in early development of thymus and CD4-expression.
3.By screening 170 cases of leukemia or related disorders, we found five (2.9%) novel mutations within the exons 3 through 6,which correspond to the runt domain. Apart from a case with a silent mutation, the remaining four cases were all loss-of-function type of the allele : Two of them were frame-shift near the N-terminus, and the other two, I150ins and K168,were insertion mutations near the C-terminal end of the runt domain which were experimentally proven to be non-functional. These data further underscore the notice that one-allele loss of AML1 serves as an early event of human leukemogenesis.

Report

(3 results)
  • 2003 Annual Research Report   Final Research Report Summary
  • 2002 Annual Research Report
  • Research Products

    (8 results)

All Other

All Publications (8 results)

  • [Publications] Nishimura, M.: "VWRPY motifdependent and -independent roles of AML1IRunx1 transcription factor in murine hematopoietic development."Blood. 103. 562-570 (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nakao, M.: "Novel loss-of-function mutations of the haematopoiesis-related transcription factor, AMLI/RUNIXi, detected in acute myeloblastic leukaemia and inyelodysplastic syndrome"British Journal of Haematology. (未定)(印刷中). (2004)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] 奥田 司: "AML1と造血発生"分子細胞治療. 1. 149-159 (2002)

    • Description
      「研究成果報告書概要(和文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nishimura M, Fukushima-Nakase Y, Fujita Y, Nakao M, Toda S, Kitamura N, Abe T, Okuda T.: "VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoictic development."Blood. 103(2). 562-570 (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nakao M, Horiike S, Fukushima-Nakase Y, Nishimura M, Fujita Y, Taniwaki M, Okuda T.: "Novel loss-of-function mutations of the haemato-poiesis-related transcription factor, AML1/RUNX1 detected in acute myeloblastic leukaemia and myelodysplastic syndrome."British Journal of Haematology. (in press). (2004)

    • Description
      「研究成果報告書概要(欧文)」より
    • Related Report
      2003 Final Research Report Summary
  • [Publications] Nishimura, M.: "VWRPY motif-dependent and -independent roles of AML1/Runx1 transcription factor in murine hematopoietic development."Blood. 103・2. 562-570 (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] Nakao, M.: "Novel loss-of-function mutations of the haematopoiesis-related transcription factor, AML1/RUNX1,detected in acute myeloblastic leukaemia and myelodysplastic syndrome"British Journal of Haematology. (印刷中). (2004)

    • Related Report
      2003 Annual Research Report
  • [Publications] 奥田 司: "AML1と造血発生"分子細胞治療. 1・2. 149-159 (2002)

    • Related Report
      2002 Annual Research Report

URL: 

Published: 2002-04-01   Modified: 2016-04-21  

Information User Guide FAQ News Terms of Use Attribution of KAKENHI

Powered by NII kakenhi